News
PRVA
18.74
+1.79%
0.33
Privia Health Is Maintained at Buy by Stifel
Dow Jones · 2d ago
Stifel Maintains Buy on Privia Health Gr, Lowers Price Target to $24
Benzinga · 2d ago
PRIVIA HEALTH GROUP INC <PRVA.O>: STIFEL CUTS TARGET PRICE TO $24 FROM $28
Reuters · 2d ago
U.S. RESEARCH ROUNDUP- Air Products and Chemicals, Geron, PayPal
Wall Street analysts revise ratings and price targets on several U.S.-listed companies. Air Products and Chemicals, Geron, PayPal, and PayPal among those revised. 3M Co, Amazon, and other companies also see price targets cut by Wall Street analysts. Some analysts raise target prices for some companies.
Reuters · 2d ago
Weekly Report: what happened at PRVA last week (0422-0426)?
Weekly Report · 4d ago
Where Privia Health Gr Stands With Analysts
Privia Health Gr (NASDAQ:PRVA) has an average price target of $27.0. The company's revenue growth over the past three months has been noteworthy. Privia Health Group Inc is a technology-driven physician-enablement company. 9 analysts have recently shared their evaluations of the company. The average 12-month price target has declined 15.99% from the prior average.
Benzinga · 04/22 16:00
Privia Health Initiated at Buy by Citigroup
Dow Jones · 04/22 13:11
Privia Health Price Target Announced at $25.00/Share by Citigroup
Dow Jones · 04/22 13:11
PRIVIA HEALTH GROUP INC <PRVA.O>: CITIGROUP INITIATES COVERAGE WITH BUY RATING; PRICE TARGET $25
Reuters · 04/22 10:12
Weekly Report: what happened at PRVA last week (0415-0419)?
Weekly Report · 04/22 09:12
Weekly Report: what happened at PRVA last week (0408-0412)?
Weekly Report · 04/15 09:11
Barclays Sticks to Its Hold Rating for Privia Health Group (PRVA)
TipRanks · 04/15 08:26
Privia Health Group, Inc.'s (NASDAQ:PRVA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Privia Health Group (NASDAQ:PRVA) has a 3.5% return on equity. The ROE is a measure of how much a company can generate from its earnings. We look at Privia Health group's net income growth over the last five years. The company has a decent ROE of 3.6%. Privia health group's ROE does not compare to its industry average of 12%. The company's stock is down 19% over the past month.
Simply Wall St · 04/08 12:27
Weekly Report: what happened at PRVA last week (0401-0405)?
Weekly Report · 04/08 09:12
Weekly Report: what happened at PRVA last week (0325-0329)?
Weekly Report · 04/01 09:12
Weekly Report: what happened at PRVA last week (0318-0322)?
Weekly Report · 03/25 09:12
Analyst Scoreboard: 8 Ratings For Privia Health Gr
8 analysts have published ratings on Privia Health Gr (NASDAQ:PRVA) in the last three months. The company has an average 12-month price target of $27.25. The average price target is lower than the previous average of $32.14. Privia health group Inc is a physician-enablement company. The firm's revenue growth over the past three months has been noteworthy.
Benzinga · 03/19 15:01
Privia Health Price Target Cut to $37.00/Share From $41.00 by Canaccord Genuity
Dow Jones · 03/19 10:56
Privia Health Is Maintained at Buy by Canaccord Genuity
Dow Jones · 03/19 10:56
Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $37
Benzinga · 03/19 10:46
More
Webull provides a variety of real-time PRVA stock news. You can receive the latest news about Privia Health Group, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About PRVA
Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improve patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The platform supports multiple provider types, enables scalable operations, and delivers patient centric in-person and virtual access to care, quality metrics, and lower cost of care. It provides management services to each Medical Group though a local management services organization.